WHO guidelines involve manufacturers to apply a continuous chance administration process for sterility test isolators, including regular possibility assessments and the development of possibility-dependent Command procedures. The risk management process commences with a thorough Assessment of likely failure modes and their prospective impacts on sterility assurance. Continue to be Successfully Submitted (Awaiting Approval)